Although mutant p53 proteins were known to accumulate at abnormally high levels in cancer cells, the observation that lysosomal inhibitors could further stabilize mutant protein abundances strongly implied that they might be continuously degraded through the lysosomal pathway. This evidence concerns the gene TP53 and cancer.